Russia remains a promising market for pharma industry, says new report
This article was originally published in Scrip
Executive Summary
Russia remains a promising market for suppliers of pharmaceuticals, medical devices and equipment, even in the current uncertain economic environment, says a new report from Frost & Sullivan. Its Overview of Pharmaceutical and Medical Devices Industry in Russia and CIS said that the government's strong support for modernising national healthcare and making it more efficient, as well as at reversing the decline in the health of the population, will be the main driver of further market growth.